← Back to projects

Ketcher — Molecule Sketcher

Ketcher is an open-source chemical structure editor used by researchers and pharmaceutical companies. Scientists draw formulas from scratch, load them from files or import them from pictures. The tool was used in drug R&D — including a COVID-19 treatment project.

DomainLife Sciences
RoleUX Researcher
TeamResearch team (2 Designers) & UI Design team (4 Designers)
TimelineJun 2021
Ketcher editor interface

Problem

The tool had grown organically over time and lacked a clear UX structure:

  • Complex interface with non-intuitive controls
  • Poor discoverability of key functions
  • No clear documentation or onboarding
  • Inconsistent experience across browsers and devices

Goal

  • Make it easier for scientists to draw, edit and export chemical structures
  • Improve navigation and reduce usage errors
  • Ensure compatibility across modern browsers
  • Retain scientific precision while improving accessibility

What I Did as UX Researcher

  • Conducted interviews with internal chemists and external open-source users
  • Researched key barriers, pain points and user needs
  • Explored pain points through recorded screen sessions and GitHub issue history
  • Ran competitive analysis of structure editors: Marvin, ChemDraw, BKChem
  • Focused on task flows for creating molecules, editing bonds and exporting data

As a UI designer, I also supported the design team with the UI kit and presentation design.

Key insight: most users only use 10–20% of the available tools — but can't find them quickly.

Research presentation: delivery persona and remote usability session with participants
Part of the research presentation
Research findings from sessions with students and experts
Findings — students & experts
Research findings: most used programs and preferred format of work
Findings — tools & usage patterns

Achievements

While interviewing students, professors and scientists, we discovered the COVID Moonshot project — an open-science effort that used Ketcher to develop a COVID-19 treatment, aiming for a cost-effective, unpatented formula any pharmaceutical company could produce globally. Our team's redesign directly supported this work.

Results

  • Cut task time (e.g. drawing and exporting) by ~30% in internal testing
  • Positive feedback from contributors: “This makes onboarding so much easier”
  • The new UI is now featured as the default demo in EPAM Life Sciences Open Source — EPAM presents it to prospective clients as a showcase of what the team can deliver
Old design / before
Old design / before
Renewed design / after
Renewed design / after